Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

8.26
Delayed Data
As of 4:00pm ET
 +0.34 / +4.29%
Today’s Change
2.20
Today|||52-Week Range
8.84
+28.86%
Year-to-Date
ImmunoGen Starts Phase I Study on Leukemia Candidate IMGN632
Jan 05 / Zacks.com - Paid Partner Content